SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

15.88p
   
  • Change Today:
    -0.38p
  • 52 Week High: 19.50
  • 52 Week Low: 7.25
  • Currency: UK Pounds
  • Shares Issued: 228.44m
  • Volume: 615,738
  • Market Cap: £36.26m
  • Beta: 1.22

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
84.04% above the market average84.04% above the market average84.04% above the market average84.04% above the market average84.04% above the market average
56.25% above the sector average56.25% above the sector average56.25% above the sector average56.25% above the sector average56.25% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
94.85% above the market average94.85% above the market average94.85% above the market average94.85% above the market average94.85% above the market average
85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average
Price Book Ratio
95.9% below the market average95.9% below the market average95.9% below the market average95.9% below the market average95.9% below the market average
86.05% below the sector average86.05% below the sector average86.05% below the sector average86.05% below the sector average86.05% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
88.39% above the market average88.39% above the market average88.39% above the market average88.39% above the market average88.39% above the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average
Price Chg 3m
93.01% above the market average93.01% above the market average93.01% above the market average93.01% above the market average93.01% above the market average
96.00% above the sector average96.00% above the sector average96.00% above the sector average96.00% above the sector average96.00% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
62.03% above the market average62.03% above the market average62.03% above the market average62.03% above the market average62.03% above the market average
56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average56.52% above the sector average
Momentum 20
52.29% above the market average52.29% above the market average52.29% above the market average52.29% above the market average52.29% above the market average
60.87% above the sector average60.87% above the sector average60.87% above the sector average60.87% above the sector average60.87% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
95.29% below the market average95.29% below the market average95.29% below the market average95.29% below the market average95.29% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
61.16% below the market average61.16% below the market average61.16% below the market average61.16% below the market average61.16% below the market average
10.2% below the sector average10.2% below the sector average10.2% below the sector average10.2% below the sector average10.2% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
92.05% below the market average92.05% below the market average92.05% below the market average92.05% below the market average92.05% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Operating Profit Loss
61.38% below the market average61.38% below the market average61.38% below the market average61.38% below the market average61.38% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
76.1% below the market average76.1% below the market average76.1% below the market average76.1% below the market average76.1% below the market average
61.7% below the sector average61.7% below the sector average61.7% below the sector average61.7% below the sector average61.7% below the sector average
Cash
52.47% below the market average52.47% below the market average52.47% below the market average52.47% below the market average52.47% below the market average
51.02% below the sector average51.02% below the sector average51.02% below the sector average51.02% below the sector average51.02% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 15.88p
Change Today -0.38p
% Change -2.31 %
52 Week High 19.50
52 Week Low 7.25
Volume 615,738
Shares Issued 228.44m
Market Cap £36.26m
Beta 1.22

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
72.99% below the market average72.99% below the market average72.99% below the market average72.99% below the market average72.99% below the market average
96% below the sector average96% below the sector average96% below the sector average96% below the sector average96% below the sector average
Price Trend
1.45% above the market average1.45% above the market average1.45% above the market average1.45% above the market average1.45% above the market average
51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average51.02% above the sector average
Income Not Available
Growth
21.88% above the market average21.88% above the market average21.88% above the market average21.88% above the market average21.88% above the market average
11.76% above the sector average11.76% above the sector average11.76% above the sector average11.76% above the sector average11.76% above the sector average

SBTX Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
15:51 7,500 @ 15.95p
14:41 100,000 @ 15.75p
14:39 100,000 @ 15.75p
15:10 6 @ 15.50p
15:10 187 @ 16.00p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page